Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
21:47:46 EDT Thu 18 Sep 2025
Enter Symbol
or Name
USA
CA



Q:APDN - APPLIED DNA SCIENCES INC - https://www.adnas.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
APDN - Q0.32.80·2.981.02.87-0.03-1.036.9952632.88  2.95  2.831,072.425  2.1319:53:53Aug 1415 min RT 2¢

Recent Trades - Last 10 of 263
Time ETExPriceChangeVolume
19:53:53Q2.980.08101
18:30:28Q2.980.083
18:29:27Q2.970.0710
18:28:57Q2.960.0610
17:12:14Q2.90 1
16:30:48Q2.910.013
16:29:08Q2.89-0.01500
16:18:31Q2.85-0.051
16:17:50Q2.90 1
16:04:09Q2.87-0.031

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2025-08-14 16:10U:APDNNews ReleaseApplied DNA Reports Third Quarter Fiscal 2025 Financial Results
2025-07-24 09:00U:APDNNews ReleaseApplied DNA Announces New Follow-On LineaDNA Order from Global IVD Manufacturer for Use in Cancer Diagnostic Application
2025-07-07 09:00U:APDNNews ReleaseApplied DNA Regains Compliance with All Nasdaq Continued Listing Requirements
2025-06-30 09:00U:APDNNews ReleaseApplied DNA Sharpens Strategic Focus on Synthetic DNA Manufacturing for Biotherapeutics Applications, Consolidates Operations Behind LineaRx
2025-06-17 16:10U:APDNNews ReleaseApplied DNA Announces Retirement of Chairperson and CEO Dr. James A. Hayward
2025-06-16 09:00U:APDNNews ReleaseApplied DNA to Resume Quarterly Investor Call Cadence Beginning with FQ3'25 Financial Results Report in Mid-August
2025-05-29 16:05U:APDNNews ReleaseApplied DNA Reschedules Intra-Quarter Webcast and Investor Update Call to June 17
2025-05-29 08:00U:APDNNews ReleaseApplied DNA Announces 1-For-15 Reverse Stock Split Effective June 2, 2025
2025-05-15 16:07U:APDNNews ReleaseApplied DNA Reports Second Quarter Fiscal 2025 Financial Results
2025-05-14 11:31U:APDNNews ReleaseApplied DNA to Announce Second Quarter Fiscal 2025 Financial Results on May 15, Schedules Intra-Quarter Investor Update Call for June 3
2025-04-21 09:02U:APDNNews ReleaseApplied DNA's LineaRx Subsidiary Stands Ready to Support the Reshoring of Drug Development and Manufacturing with U.S.-Produced Synthetic DNA
2025-04-08 09:03U:APDNNews ReleaseApplied DNA Regains Compliance with Nasdaq Minimum Bid Price Requirement
2025-04-01 09:46U:APDNNews ReleaseApplied DNA Positions TR8 PGx Testing Service as Pre-Emptive Testing for Safety of Fluoropyrimidine-Based Cancer Therapeutics Following Publication of Food and Drug Administration Safety Announcement
2025-03-26 09:02U:APDNNews ReleaseApplied DNA Submits Validation Package to New York State Department of Health for H5 Bird Flu/Pan-Influenza A Laboratory-Developed Test
2025-03-12 08:05U:APDNNews ReleaseApplied DNA Announces 1-For-50 Reverse Stock Split Effective March 14, 2025
2025-02-13 16:05U:APDNNews ReleaseApplied DNA Reports First Quarter Fiscal 2025 Financial Results and Highlights Operational Progress
2025-02-12 12:02U:APDNNews ReleaseApplied DNA to Report First Quarter Fiscal 2025 Financial Results After Market Close on Thursday, February 13, 2025
2025-02-11 08:33U:APDNNews ReleaseApplied DNA Reminds Shareholders to Vote Ahead of Special Meeting on February 14
2025-01-10 09:02U:APDNNews ReleaseApplied DNA Completes Buildout of GMP Facility for LineaDNA IVT Templates
2025-01-08 16:31U:APDNNews ReleaseApplied DNA Reschedules Investor Update Call in Observance of the National Day of Mourning in Recognition of the Passing of Former President Jimmy Carter